[ Price : $8.95]
Janssen and Novavax report positive data from Phase 3 clinical trials involving each of their investigational Covid-19 vaccines.[ Price : $8.95]
FDA extends by three months the review of a Biogen BLA for aducanumab, indicated for treating Alzheimers disease.[ Price : $8.95]
FDA approves a Medtronic PMA for the DiamondTemp Ablation system for treating patients with recurrent, symptomatic paroxysmal atri...[ Price : $8.95]
FDA classifies as Class 1 a Penumbra recall of its Jet 7 Xtra Flex catheter due to its potentially becoming susceptible to distal ...[ Price : $8.95]
FDA clears a Vertex Pharmaceuticals IND to proceed with a clinical trial for VX-880, an investigational cell therapy for treating ...[ Price : $8.95]
FDA grants Ascentage Pharma an orphan drug designation for its novel Bcl-2 inhibitor, APG-2575, for treating patients with follicu...[ Price : $8.95]
The CDER Office of Prescription Drug Promotion releases performance metrics on three measures for the first quarter of the current...[ Price : $8.95]
FDA clears a Perspectum 510(k) for Hepatica, a precision oncology decision support tool for liver cancer.